PHOEBE OAKES: Open Payments
NPI 1801096664 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 59 payments from 19 companies in 2025. Trend: 2023 $840 · 2024 $1,067 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $296 |
| Esperion Therapeutics, Inc. | 6 | $121 |
| PFIZER INC. | 5 | $117 |
| Novo Nordisk Inc | 5 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Amgen Inc. | 4 | $72 |
| Astellas Pharma US Inc | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| GlaxoSmithKline, LLC. | 3 | $42 |
Products named: QULIPTA, NEXLETOL, NURTEC ODT, UBRELVY, GEMTESA, Ozempic, Veozah, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
